Platelet count >= 100,000/mm�
700.0
Platelet (PLTs) count >= 100,000/mm^3 obtained =< 21 days prior to registration
360.0
Platelet count >= 100,000 cells/mcL
155.0
Peripheral platelet count (PLT) >= 75,000/mm^3
48.0
Platelet count >= 100,000/mm^3
1120.0
Platelet count > 100,000
224.0
Platelet count >= 100,000/mL within 28 days prior to registration
1900.0
STEP I: Untransfused platelet count >= 75,000 cells/mm^3 (obtained within 28 days prior to randomization)
1080.0
Platelet count < 100 x 10^9/L
45.0
Platelet count > 100,000/mm^3
2060.0
Platelet count >= 50 x 10^9/L
97.0
Platelet count >= 75,000/mm^3 within 90 days prior to randomization
150.0
Platelet count >= 100,000/mm^3
34.0
Platelet count >= 100,000 mcl obtained within 28 days prior to sub-study registration
10000.0
Platelet count >= 100 x 10^9/L
250.0
Platelet count >= 100 x 10^9/L measured within 28 days prior to randomization
1500.0
Platelet count >= 100,000/mm^3
20.0
Platelet count >= 100,000/mcL
600.0
Patients on Part C with acute lymphoblastic leukemia: platelet count >= 20,000/mm^3 (may receive platelet transfusions); these patients must not be known to be refractory to red cell or platelet transfusion
148.0
Platelet count > 50,000/mm^3
125.0
Platelet count >= 75,000/mm^3
30.0
Platelet count >= 100,000/mm^3
420.0
Within 6 weeks prior to randomization: Platelet count must be >= 100,000/mm^3
990.0
Platelet count >= 100,000/mm^3
195.0
Re-registration: platelet count >= 100,000/mm^3
195.0
Within 14 days of registration: Platelet count >= 75,000/mm^3
110.0
Platelet count >= 100,000/mm^3
69.0
Platelet count >= 100,000/mm^3
130.0
Platelet count >= 100,000/mm^3
45.0
Platelet count >= 75,000/mcL; must be obtained within 28 days prior to registration
180.0
Platelet count >= 100,000/ mL within 21 days prior to registration
333.0
Platelet count >= 100,000/mm^3
137.0
CLINICAL/LABORATORY CRITERIA: Platelet count >= 100,000/mcL; these results must be obtained within 28 days prior to registration
53.0
Platelet count must be >= 100,000/mm^3 within 28 days before randomization
348.0
Platelet count >= 100,000/mm^3, within 4 weeks of randomization
766.0
Platelet count >= 100,000/mm^3
124.0
Platelet count >= 100,000 mm^3; platelets >= 75,000 required for patients who received cycle 1 of mFOLFOX6 prior to registration
700.0
Platelet count < 100 x 10^9/L
98.0
Platelet count >= 75,000/mm^3
324.0